pharmaceuticals-and-healthcare

2017-2022 Antibody Drug Conjugate Report on Global and United States Market, Status and Forecast, by Players, Types and Applications


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 135 pages

  • $2960
  • $5920

Please click below to avail discount on this report

This report studies the Antibody Drug Conjugate market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Antibody Drug Conjugate market by product type and applications/end industries.

The global Antibody Drug Conjugate market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antibody Drug Conjugate. United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast), covering
United States
North America
Europe
Asia-Pacific
South America
Middle East and Africa

The major players in global and United States Antibody Drug Conjugate market, including ImmunoGen, Seattle Genetics, Immunomedics, Pfizer, Roche / Genentech, Celldex Therapeutics, Millennium Pharmaceuticals, AbbVie, Bayer HealthCare, Astellas Pharma/Agensys, Progenics Pharmaceuticals, Mersana Therapeutics, Synthon, Heidelberg Pharma, Oxford BioTherapeutics


The On the basis of product, the Antibody Drug Conjugate market is primarily split into
Adcetris
Kadcyl
Others

On the basis on the end users/applications, this report covers
Multiple Myeloma
Solid Tumours
Bladder Cancer
Kidney Cancer
Ovarian Cancer
Breast Cancer
Glioblastoma
Lung Cancer
Colorectal Cancer
Prostate Cancer

In the recent times, the global market for 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications production processes, which is also reflecting positively on the growth of this market.

The research report on the 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications, including the definition, classification, and industry chain structure of 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications in details. It provides in-depth information on the development trends and the policies and regulations, concerning 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications, implemented in each of the geographical segments. The predominant applications of the 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the 2017 2022 antibody drug conjugate report on global and united states market status and forecast by players types and applications from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Antibody Drug Conjugate Product Picture
Figure Global Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2012-2022)
Figure United States Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2012-2022)
Figure Product Picture of Adcetris
Table Major Players of Adcetris
Figure Global Adcetris Sales (Ton) and Growth Rate (%) (2012-2017)
Figure Product Picture of Kadcyl
Table Major Players of Kadcyl
Figure Global Kadcyl Sales (Ton) and Growth Rate (%) (2012-2017)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (Ton) and Growth Rate (%) (2012-2017)
Table Global Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022)
Table Global Antibody Drug Conjugate Sales (Ton) by Types (2012-2017)
Table Global Antibody Drug Conjugate Sales Share (%) by Types (2012-2017)
Figure Global Sales Antibody Drug Conjugate Market Share (%) by Types (2012-2017)
Figure Global Sales Antibody Drug Conjugate Market Share (%) by Types in 2016
Table Global Antibody Drug Conjugate Revenue (Million USD) by Types (2012-2017)
Table Global Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017)
Figure Global Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Revenue Market Share (%) by Types
Table Global Antibody Drug Conjugate Price (USD/Kg) by Types (2012-2017)
Table United States Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Comparison by Types (2012, 2016 and 2022)
Table United States Antibody Drug Conjugate Sales (Ton) by Types (2012-2017)
Table United States Antibody Drug Conjugate Sales Share (%) by Types (2012-2017)
Figure United States Sales Antibody Drug Conjugate Market Share (%) by Types (2012-2017)
Figure United States Sales Antibody Drug Conjugate Market Share (%) by Types in 2016
Table United States Antibody Drug Conjugate Revenue (Million USD) by Types (2012-2017)
Table United States Antibody Drug Conjugate Revenue Share (%) by Types (2012-2017)
Figure United States Antibody Drug Conjugate Revenue Share (%)by Types (2012-2017)
Figure 2016 United States Antibody Drug Conjugate Revenue Market Share (%) by Types
Table United States Antibody Drug Conjugate Price (USD/Kg) by Types (2012-2017)
Figure Multiple Myeloma Examples
Figure Solid Tumours Examples
Figure Bladder Cancer Examples
Figure Kidney Cancer Examples
Figure Ovarian Cancer Examples
Table United States Antibody Drug Conjugate Sales (Ton) Comparison by Applications (2012-2022)
Table Global Antibody Drug Conjugate Sales (Ton) by Applications (2012-2017)
Table Global Antibody Drug Conjugate Sales Share (%) by Applications (2012-2017)
Figure Global Sales Antibody Drug Conjugate Market Share (%) by Applications (2012-2017)
Figure Global Sales Antibody Drug Conjugate Market Share (%) by Applications in 2016
Table United States Antibody Drug Conjugate Sales (Ton) Comparison by Applications (2012-2022)
Table United States Antibody Drug Conjugate Sales (Ton) by Applications (2012-2017)
Table United States Antibody Drug Conjugate Sales Share (%) by Applications (2012-2017)
Figure United States Sales Antibody Drug Conjugate Market Share (%) by Applications (2012-2017)
Figure United States Sales Antibody Drug Conjugate Market Share (%) by Applications in 2016
Table Global Antibody Drug Conjugate Revenue (Million USD) and CAGR Comparison by Regions (2012-2022)
Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Asia-Pacific Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure South America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure Middle East and Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) (2012-2022)
Table Global Antibody Drug Conjugate Sales (Ton) by Regions (2012-2017)
Figure Global Antibody Drug Conjugate Sales Market Share (%) by Regions (2012-2017)
Figure Global Antibody Drug Conjugate Sales Market Share (%) by Regions (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Sales Market Share (%) by Regions
Figure 2016 United States Antibody Drug Conjugate Sales Market Share (%) in Global Market
Table Global Antibody Drug Conjugate Revenue (Million USD) by Regions (2012-2017)
Table Global Antibody Drug Conjugate Revenue Market Share (%) by Regions (2012-2017)
Figure Global Antibody Drug Conjugate Revenue Market Share (%) by Regions (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Revenue Market Share (%) by Regions
Table Global Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table North America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table Europe Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table Asia-Pacific Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table South America Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table Middle East and Africa Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table United States Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Table Global Antibody Drug Conjugate Sales (Ton) of Key Players (2012-2017)
Table Global Antibody Drug Conjugate Sales Share (%) by Players (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Sales Share (%) by Players
Figure 2017 Global Antibody Drug Conjugate Sales Share (%) by Players
Table Global Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017)
Table Global Antibody Drug Conjugate Revenue Share (%) by Players (2012-2017)
Table 2016 Global Antibody Drug Conjugate Revenue Share (%) by Players
Table 2016 Global Antibody Drug Conjugate Revenue Share (%) by Players
Table Global Market Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017)
Table United States Antibody Drug Conjugate Top Players Manufacturing Base Distribution and Sales Area
Table United States Antibody Drug Conjugate Top Players Product Category
Figure Global Antibody Drug Conjugate Market Share (%) of Top 3 Players
Figure Global Antibody Drug Conjugate Market Share (%) of Top 5 Players
Table United States Antibody Drug Conjugate Sales (Ton) by Players (2012-2017)
Table United States Antibody Drug Conjugate Sales Market Share (%) by Players (2012-2017)
Figure 2016 United States Antibody Drug Conjugate Sales Share (%) by Players
Figure 2017 United States Antibody Drug Conjugate Sales Share (%) by Players
Table United States Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017)
Table United States Antibody Drug Conjugate Revenue Market Share (%) by Players (2012-2017)
Table 2016 United States Antibody Drug Conjugate Revenue Share (%) by Players
Table 2016 United States Antibody Drug Conjugate Revenue Share (%) by Players
Table United States Market Antibody Drug Conjugate Average Price (USD/Kg) by Players (2012-2017)
Figure United States Antibody Drug Conjugate Market Share (%) of Top 3 Players
Figure United States Antibody Drug Conjugate Market Share (%) of Top 5 Players
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Seattle Genetics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Pfizer Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Roche / Genentech Basic Information List
Table Roche / Genentech Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Roche / Genentech Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Roche / Genentech Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Roche / Genentech Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Millennium Pharmaceuticals Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%)(2012-2017)
Figure AbbVie Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure AbbVie Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure AbbVie Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Astellas Pharma/Agensys Basic Information List
Table Astellas Pharma/Agensys Antibody Drug Conjugate Sales (Ton), Revenue (Million USD), Price (USD/Kg) and Gross Margin (%) (2012-2017)
Figure Astellas Pharma/Agensys Antibody Drug Conjugate Sales Growth Rate (2012-2017)
Figure Astellas Pharma/Agensys Antibody Drug Conjugate Sales Global Market Share (%) (2012-2017)
Figure Astellas Pharma/Agensys Antibody Drug Conjugate Revenue Global Market Share (%) (2012-2017)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure Global Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States Antibody Drug ConjugateAntibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure United States Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Table Global Antibody Drug Conjugate Sales (Ton) Forecast by Regions (2017-2022)
Figure Global Antibody Drug Conjugate Sales Market Share (%) Forecast by Regions (2017-2022)
Figure North America Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure North America Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Europe Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Europe Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Asia-Pacific Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022)
Figure South America Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure South America Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Antibody Drug Conjugate Sales (Ton) and Growth Rate (%) Forecast (2017-2022)
Figure Middle East and Africa Antibody Drug Conjugate Revenue and Growth Rate (%) Forecast (2017-2022)
Table Global Antibody Drug Conjugate Sales (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugate Sales Market Share (%) Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugate Revenue Market Share (%) Forecast by Type (2017-2022)
Table United States Antibody Drug Conjugate Sales (Million USD) Forecast by Type (2017-2022)
Figure United States Antibody Drug Conjugate Sales Market Share (%) Forecast by Type (2017-2022)
Table United States Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2017-2022)
Figure United States Antibody Drug Conjugate Revenue Market Share (%) Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022)
Figure Global Antibody Drug Conjugate Sales Forecast by Application (2017-2022)
Table United States Antibody Drug Conjugate Sales (Ton) Forecast by Application (2017-2022)
Figure United States Antibody Drug Conjugate Sales Forecast by Application (2017-2022)

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top